NCT06383000

Brief Summary

The goal of this observational study is to assess whether the continuous non-invasive haemodynamic monitor MOH200 (measuring blood pressure as well as pulse rate) is effective or not in people undergoing general anesthetic surgeries for more than 60 minutes with planned invasive blood pressure and pulse oximeter monitoring. Researchers will compare blood pressure data derived from MOH200 to the invasive blood pressure (IBP) data to see if the MOH200 is effective to measure the blood pressure of a surgical person. Also, researchers will compare pulse rate data drived from MOH200 to that from the pulse oximeter to see if the MOH200 is effective to measure the pulse rate of a surgical person. Participants will be asked to be applied with MOH200 monitoring while IBP monitoring and pulse oximeter are applied. And after 30 minutes of the surgery, researchers will monitor the adverse effects occurred on the skin of participants to assess the safety of MOH200.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
55

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

April 25, 2024

Status Verified

April 1, 2024

Enrollment Period

7 months

First QC Date

April 22, 2024

Last Update Submit

April 22, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Continuous Non -invasive Blood Pressure Measurement from MOH200

    The blood pressure is measured by MOH200 and recorded on the CRF for every 5 minutes, including mean blood pressure, diastolic blood pressure and systolic blood pressure.

    During the surgery

  • Invasive Blood Pressure Measurement from Arterial Line

    The blood pressure is synchronously measured by the radial arterial line and also recorded on the CRF for every 5 minutes, including mean arterial pressure, diastolic blood pressure and systolic blood pressure.

    During the surgery

  • Pulse Rate Measurement from MOH200

    The pulse rate is measured by the MOH200 and recorded on the CRF for every 5 minutes.

    During the surgery

  • Pulse Rate Measurement from Pulse Oximeter

    The pulse rate is measured by the pulse oximeter and recorded on the CRF for every 5 minutes during the surgery.

    During the surgery

Secondary Outcomes (1)

  • The Occurrence of Pressure Pores

    Once after all the subjects are recruited and the clinical trials are finished

Eligibility Criteria

Age4 Years - 80 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients are going to undergoing a general anesthetic surgery for more than 60 minutes at the site (Tongji Hospital, Tongji Medical College of HUST) who are accord with the inclusion criteria and do not satisfy the exclusion criteria.

You may qualify if:

  • Patients undergoing general anesthesia surgeries for more than 60 minutes with IBP monitoring
  • Patients aging between 4 to 80 years old (including at least 5 pediatric subjects between 4 to 12 years old, and as for subjects over 12 years old, up to 60% of subjects between 12 to 50 years old, at least 15% of subjects between 50 to 60 years old, at least 15% of subjects between 60 to 70 years old, and at least 10% of subjects over 70 years old)
  • At least 30% of subjects is male and 30% is female
  • Volunteer to participate the study and sign the informed consent form willingly

You may not qualify if:

  • Patients with severe heart diseases which affect the stability of haemodynamics
  • Patients applied with the heart-lung machine, defibrillator or cardiopulmonary bypass
  • Patients with coagulation disorders, vasculopathy or vascular prostheses
  • Patients with cutaneous diseases, infections or trauma of the measured part of the body leading to failure of data acquisition
  • Patients with mental diseases, epilepsy or other diseases leading to involuntrary movements of the body
  • Patients with BMI no more than 17 or no less than 30 kg/m\^2
  • Patients who are pregnant or at the unstable stage of diseases or with severe shock
  • Patients with infections or trauma at the position of artery cannulation, whose pulse is untouchable or who get positive in the Allen's test
  • Patients with diseases that the investigators think unsuitable for participating the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Zhiqiang Zhou

    Department of Anesthesiology, Tongji Hospital, Tongji Medical College of HUST

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2024

First Posted

April 25, 2024

Study Start

June 1, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

April 25, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share